President Trump issued Nov. 4 executive orders implementing two aspects of the trade and economic agreement he reached with China in late October.
Fentanyl tariff – The additional tariff imposed on imports from China due to concerns about flows of fentanyl and precursor chemicals from that country will be lowered from 20 percent to 10 percent, effective with respect to goods entered or withdrawn from warehouse for consumption on or after 12:01 a.m. EST on Nov. 10, 2025.
“Reciprocal” tariff – The 10 percent additional tariff imposed on imports from China in response to the U.S. trade deficit with that country will remain at 10 percent until 12:01 a.m. EST on Nov. 10, 2026. This tariff had been scheduled to increase to 34 percent as of Nov. 10, 2025.
The EOs said these changes could be modified if China fails to implement related commitments outlined in the trade agreement or if deemed necessary to address the conditions underlying the original imposition of these tariffs.
It is important to note that all U.S. imports from China also remain subject to applicable most-favored-nation duty rates and that many imports are still subject to longstanding Section 301 tariffs of 7.5 to 100 percent.
Copyright © 2026 Sandler, Travis & Rosenberg, P.A.; WorldTrade Interactive, Inc. All rights reserved.
Related Trade Report Articles
- October 23, 2026 | Trade Report Learn More
USDA to Play Role in Preferential Tariff Treatment for Apparel Imports
Duty Savings, Tariff Mitigation & Supply Chain Efficiencies, Textile & Apparel
- October 22, 2026 | Trade Report Learn More
Section 338 Tariffs on Imports from Canada Challenged in Court
Duty Savings, Tariff Mitigation & Supply Chain Efficiencies, Customs & International Trade Settlement / Litigation
- October 15, 2026 | Trade Report Learn More
Mitigating Tariffs – Your Three-Pronged Strategy
Duty Savings, Tariff Mitigation & Supply Chain Efficiencies
- October 8, 2026 | Trade Report Learn More
Section 301 Tariffs on Imports from China Officially Continued
Duty Savings, Tariff Mitigation & Supply Chain Efficiencies, Section 232, 301 & Other Trade Remedy Tariff Exclusion Opportunities
- September 24, 2026 | Trade Report Learn More
Drug Products Exempt from Section 232 Tariffs Defined
Duty Savings, Tariff Mitigation & Supply Chain Efficiencies, Section 232, 301 & Other Trade Remedy Tariff Exclusion Opportunities, Life Sciences
- September 18, 2026 | Trade Report Learn More
Congress Approves New Tariff Authority
Duty Savings, Tariff Mitigation & Supply Chain Efficiencies